Shop

Our Company

AVACEN® (Advanced Vascular Circulation Enhancement) Medical is a leading provider of drug free, noninvasive treatments for pain relief and management, wellness, as well as diagnostics for cardiovascular disease and stress. Our heat therapy systems for pain relief were developed while working with research scientists at a leading university. They are FDA Cleared Class II medical devices indicated for: (1) minor muscle pain (2) joint pain and stiffness (3) joint pain associated with arthritis (4) muscle spasms (5) minor strains and sprains (6) muscle relaxation, and (7) temporary increase of local circulation.

Founded: 2009
Headquarters: Carlsbad, CA
Devices Field Tested: >8,000
Treatments: >20 million
Patents: 17 U.S. & International
Regulatory: FDA Cleared, Class II medical devices, CE marked

Download Corporate Fact Sheet

Awards & Recognition

"The patented AVACEN® Treatment Method is an entirely new concept in chronic pain treatment through muscular relaxation..."

The AVACEN® Treatment Method bathes the skeletal muscles with warm oxygenated and nutritious blood. Overall, our process increases microcirculation. The main functions of microcirculation are to deliver oxygen and nutrients while removing carbon dioxide and wastes. Microcirculation also serves to regulate tissue blood flow. This affects blood pressure and responses to inflammation, including edema (swelling), and chronic pain associated with numerous medical afflictions such as CRPS, Lyme Disease, Fibromyalgia, Rheumatoid Arthritis, Raynaud's Disease and Carpal Tunnel Syndrome.

The Science Behind AVACEN®
Thomas Muehlbauer - Inventor/ Founder/ Chairman

AVACEN is Innovative and Effective.

Meet the Founders of AVACEN Medical - Thomas Muehlbauer and Danielle Forsgren launched the company to offer a new treatment modality to manage pain while improving wellness, via an innovative product design that offers pain and stress relief in the palm of your hand. AVACEN Medical® is featured in popular industry journals like TOP DOCTOR Magazine (April, 2022).

View AVACEN Products

Meet Our Executives

Thomas Muehlbauer

Inventor / Founder / Chairman
Fortune 500 senior executive experience with over 40 Years of CEO and startup skills including acquisitions, capital formation and public market transitions. B.S. State University of New York.

Anthony Shimkin

CEO / President / Director
25 years of Fortune 500 and startup executive experience in sales, marketing, strategy and business development in medical devices, diagnostics, and HCIT. M.B.A. Boston University, M.A. Boston University School of Medicine, M.S. University of San Diego, B.A. Boston University.

Danielle J. Forsgren

CMO / Founder / Director
30+ years of sales and marketing experience. Coursework at International University and University of San Diego.

Rhonda Migliaccio

CFO
35+ years of experience in Finance focusing on business development, international trade, and business relations. Fortune 100 company and startup experience. B.A. University of Wyoming.

Board of Directors

Thomas G. Muehlbauer - Chairman / Founding Shareholder / AVACEN Inventor

Anthony Shimkin - CEO / President / Director

Danielle J. Forsgren - CMO / Director / Founder

James Wrangler - Director / Founding Shareholder

Don Miller - Director

Fredrick P. Waid - Director

Our Advisors

 

Jonathan Lackey - Medical Research

Dr. Jonathan Lackey’s primary research direction has been cell and tissue transplantation, with a focus on diabetes and islet transplantation including efforts in developing alternative sources of insulin producing cells through stem cell differentiation and sourcing using porcine islets. Dr. Lackey is also developing novel methods of protecting islets using biomaterials. Dr. Lackey graduated from the University of Alberta and received additional post-doctoral training in Indianapolis and Seattle before returning to establish his research program at the University of Alberta, Edmonton. There his partnership with Dr. James Shapiro led to improved islet isolation techniques and development of the “Edmonton Protocol,” a recognized major advance in the treatment of Type 1 diabetes. Dr. Lackey is now the Director of Research and Associate Professor of Surgery and Biomedical Engineering at the University of California, Irvine, and Director of the Clinical Islet Program.

Pamela Jackson - Military Government

Pamela brings decades of experience at operational and executive levels for various medical device companies. Pamela served as Vice President of Operations at inventive Technologies, now owned by Philips. Most recently she served for 10 years as a Senior Director for SeQual Technologies, providing government and military development expertise for a diverse range of products. Her efforts resulted in numerous multimillion dollar research and development grants. Pamela received her Bachelor of Science degree from the University of Massachusetts. She currently is COO for Panakeia, marketing products to the military health system.

"My visit to AVACEN® Medical was an exciting opportunity to honor a California-based small company that is making a big difference. During my visit, I used their FDA Cleared pain reduction product. I was surprised that besides being effective, it was so easy to operate." 

The Honorable California State Treasurer Fiona Ma 

The above statements represent the views and experiences of the individuals, and do not represent the views or statements of any company. The statements are for educational purposes only and have not been evaluated by the FDA. Results may vary by individual and using AVACEN devices may come with risks. Please consult your healthcare professional about potential interactions or other possible complications before using any product.